We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Droplet PCR System Identifies Fetal Genetic Data

By HospiMedica International staff writers
Posted on 24 Nov 2015
Print article
A new study describes a simple, accurate, and low risk blood test that can detect fetal blood group, sex, and genetic conditions from a maternal blood sample.

Developed by researchers at Plymouth University (United Kingdom), the new noninvasive fetal Rh blood group and D antigen (RhD) genotyping test can help prevent unnecessary administration of prophylactic anti-D to women carrying RHD-negative fetuses. The blood sample can be taken from the mother when she has her first appointment with a general practitioner (GP) or midwife at the early stages of pregnancy, negating the need for multiple appointments and making best use of healthcare resources.

A study to validate the new test, which is based on a novel droplet digital polymerase chain reaction (ddPCR) platform to detect the cell-free fetal DNA (cffDNA) fraction, found that dPCR demonstrated 100% sensitivity for both fetal sex determination and RHD genotyping. The test can also be carried out on mothers at risk of X-linked genetic recessive diseases, including hemophilia and Duchenne muscular dystrophy, as well as mothers at risk of hemolytic disease of the newborn. The study was published in the November 2015 issue of Clinical Chemistry.

“Use of dPCR for identification of fetal specific markers can reduce the occurrence of false-negative and inconclusive results, particularly when samples express high levels of background maternal cell-free DNA,” concluded senior author Prof. Neil Avent, PhD, of the Plymouth University School of Biomedical and Healthcare Sciences. “The technique represents a comparatively low-risk method for the early identification of a number of conditions, which in turn will aid earlier diagnosis and possible therapies to the potential benefit of both mother and child.”

ddPCR is based on water-oil emulsion droplet technology; a sample is fractionated into 20,000 nanoliter-sized droplets, serving essentially the same function as individual test tubes or wells in a PCR plate, albeit in a much smaller format. The massive sample partitioning is a key aspect of the ddPCR technology, enabling high-throughput digital PCR in a manner that uses lower sample and reagent volumes and reduces overall cost, while still maintaining the sensitivity and precision of current digital PCR systems.

Related Links:

Plymouth University


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Mobile Cordless Cast Saw
CleanCast CSB-100
New
Mobile Cart
MS400

Print article

Channels

Surgical Techniques

view channel
Image: Molecular imaging of the adrenal glands in three patients (Photo courtesy of QMUL)

Endoscopic Ultrasound-Guided Procedure Could Transform Blood Pressure Management

Primary aldosteronism (PA) is a hormonal disorder that causes high blood pressure in approximately one in 20 patients with hypertension but often goes undiagnosed and untreated. In this condition, benign... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.